Pathogenesis and clinical management of Helicobacter pylori gastric infection.
de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, Neves PHM, de Melo FF.
World J Gastroenterol. 2019 Oct 7;25(37):5578-5589. doi: 10.3748/wjg.v25.i37.5578.
Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors.
Muzaheed.
ScientificWorldJournal. 2020 Jul 12;2020:3018326. doi: 10.1155/2020/3018326. eCollection 2020.
Pathogenicity and virulence of Helicobacter pylori: A paradigm of chronic infection.
Clyne M, Ó Cróinín T.
Virulence. 2025 Dec;16(1):2438735. doi: 10.1080/21505594.2024.2438735. Epub 2024 Dec 26.
Helicobacter pylori infection status and evolution of gastric cancer.
Zhang W, Zhang Y, Ning J, Fu W, Ding S.
Chin Med J (Engl). 2025 Dec 5;138(23):3083-3096. doi: 10.1097/CM9.0000000000003903. Epub 2025 Nov 13.
Is Helicobacter pylori infection protective against esophageal cancer?
Maity R, Dhali A, Biswas J.
World J Gastroenterol. 2024 Oct 14;30(38):4168-4174. doi: 10.3748/wjg.v30.i38.4168.
Programmed cell death in Helicobacter pylori infection and related gastric cancer.
Lin Y, Liu K, Lu F, Zhai C, Cheng F.
Front Cell Infect Microbiol. 2024 Jul 31;14:1416819. doi: 10.3389/fcimb.2024.1416819. eCollection 2024.
Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer.
Alipour M.
J Gastrointest Cancer. 2021 Mar;52(1):23-30. doi: 10.1007/s12029-020-00518-5. Epub 2020 Sep 14.
Impacts of Helicobacter pylori infection and eradication on gastrointestinal microbiota: An up-to-date critical review and future perspectives.
Li Y, He C, Lu N.
Chin Med J (Engl). 2024 Dec 5;137(23):2833-2842. doi: 10.1097/CM9.0000000000003348. Epub 2024 Nov 6.
Helicobacter pylori infection and drugs malabsorption.
Lahner E, Virili C, Santaguida MG, Annibale B, Centanni M.
World J Gastroenterol. 2014 Aug 14;20(30):10331-7. doi: 10.3748/wjg.v20.i30.10331.
Helicobacter pylori infection: an overview in 2013, focus on therapy.
Cui R, Zhou L.
Chin Med J (Engl). 2014;127(3):568-73.
